Chinese Drug Developer Firm Connect Biopharmaceuticals Completes $55 Million Series B Round

News Source: China Money Network.

Connect Biopharmaceuticals, a clinical-stage biotech medicine developer, has completed a US$55 million series B round of financing, led by private equity Advantech Capital, according to a company announcement released today.

Continue Reading the Entire Article Here >>

This news article comes via China Money Network, who is the copyright owner of this information and news. has licensed the rights to this article and any republication or re-distribution in whole or in part of this content is strictly prohibited without the express consent of

You May Also Like